Cytokines and Exocrine Pancreatic Cancer: Is There a Link?
Abstract
No abstract available.
Image: Schematic representation of TGFbeta1 signal transduction pathway via Smad proteins.
Downloads
References
Warshaw AL, Fernandes del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326:455-65.
Kern SE. Advances from genetic clues in pancreatic cancer. Current Opinion in Oncology 1998; 10:74-80.
Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102:230-6.
Byrne JL, Marshall CJ.The molecular pathophysiology of myeloid leukaemias: Ras revisited. Br J Haematol 1998; 100:256-64.
Bleday R, Tzanakakis GN, Schwalke MA, Wanebo HJ, Vezeridis MP. Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res 1990; 49:276-9.
Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992; 90:1352-60. [93016866]
Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Klöppel G, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992; 166:7-12.
Basso D, Plebani M, Fogar P, Panozzo MP, Meggiato T, De Paoli M, et al. Insulin- like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int J Clin Lab Res 1995;25:40-3.
Schmielau J, Kalthoff H, Roeder C, Schmiegel W. The role of cytokines in pancreatic cancer. Int J Pancreatol 1996; 19:157-63. [96400984]
Schlosser S, Gansauge F, Schnelldorfer T, Ramadani M, Schwarz A, Beger HG, Gansauge S. Inhibition of epidermal growth factor-induced interleukin-1beta-converting enzyme expression reduces proliferation in the pancreatic carcinoma cell line AsPC-1. Cancer Res 1999; 59:4551-4. [99421248]
Ohba N, Funatomi H, Seki T, Makino R, Mitamura K. Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor alpha mRNA in AsPC-1 human pancreatic cancer cells. J Gastroenterol 1999; 34:498-504.
Birk D, Gansauge F, Gansauge S, Formentini A, Lucht A, Beger HG. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1999; 25:89-96.
Burtscher I, Compagni A, Lamm GM, Christofori G. An insulin-like growth factor- mediated, phosphatidylinositol 3’ kinase- independent survival signaling pathway in beta tumor cells. Cancer Res 1999; 59:3923-6.
Ono M, Torisu H, Fukushi JI, Nishie A, Kuwano M. Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol 1999; 43(Suppl):S69-71.
Schwiebert LM, Estell K, Propst SM. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol 1999; 276:C700-10.
Davis R. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268:14553-6.
Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80:179-85.
Seufferlein T, van Lint J, Liptay S, Adler G, Schmid RM. Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations. Gastroenterology 1999; 116:1441-52.
Manning AM, Williams AC, Game SM, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 1991; 6:1471-6.
Panozzo MP, Basso D, De Paoli M, Carraro P, Burighel D, Plebani M. Cytokines may influence tumor growth and spread. An in vitro study in two human cancer cell lines. Int J Clin Lab Res 1996; 26:240-4.
Iacopetta BJ, Welch J, Soong R, House AK, Zhou XP, Hamelin R. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations. J Pathol 1998; 184:390-5.
Le Dai J, Schutte M, Bansal RK, Wilentz RE, Sugar AY, Kern SE. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol Carcinog 1999; 26:37-43. [99415461]
Schutte M. DPC4/SMAD4 gene alterations in human cancer, and their functional implications. Ann Oncol 1999; 10(Suppl 4):S56-9.
Ellenrieder V, Adler G, Gress TM. Invasion and metastasis in pancreatic cancer. Ann Oncol 1999; 10(Suppl 4):S46-50.
Shimoyama S, Gansauge F, Gansauge S, Kaminishi M, Beger HG. Basal expression and cytokine induction of intercellular adhesion molecule-1 in human pancreatic cancer cell lines. J Exp Clin Cancer Res 1999; 18:107-10.
Stefani AL, Basso D, Panozzo MP, Greco E, Mazza S, Zancanaro F, et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 1999; 19:362-9. [20012687]
Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990; 50:4771-5.
Vidal Vanaclocha F, Amézaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 1994; 54:2667-72.
Shi Q, Abbruzzese JL, Huang S, Fidler IJ, Xiong Q, Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 1999; 5:3711-21. [20055708]
McKenzie IFC, Apostolopoulos V. Towards immunotherapy of pancreatic cancer. Gut 1999; 44:767-9.
Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, et al. Tumor-associated transforming growth factor- beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol 1999; 155:537-47.
Kimura M, Yoshida Y, Narita M, Takenaga K, Takenouchi T, Yamaguchi T, et al. Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti- tumor effect generated by in vivo gene transfer using retrovirus. Int J Cancer 1999; 82:549-55.
Aspinall RJ, Lemoine NR. Gene therapy for pancreatic and biliary malignancies. Ann Oncol 1999; 10(Suppl 4):S188-92.
Fan Z, Mendelsohn J. Therapeutic application of anti-growth factor receptor antibodies. Current Opinion in Oncology 1998; 10:67-73.
van Hinsbergh VWM, Collen A, Koolwijk P. Angiogenesis and anti- angiogenenesis: perspectives for the treatment of solid tumors. Ann Oncol 1999; 10(Suppl 4):S69-3.
Copyright (c) 2000 Daniela Basso, Mario Plebani
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.